详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

Recent developments and highlights in allergic rhinitis

0| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China [2]Beijing Inst Otolaryngol, Beijing Key Lab Nasal Dis, Beijing, Peoples R China [3]Capital Med Univ, Beijing TongRen Hosp, Dept Allergy, Beijing, Peoples R China

出处：

DOI：

ISSN：

关键词： allergic rhinitis biologics epigenetics risk factors treatment

摘要：

Allergic rhinitis (AR) is a disease with high prevalence all over the world and therefore needs to be thoroughly investigated and treated accordingly. The mechanisms underlying the pathology and treatment of AR have been widely studied, but many aspects remain unclear and warrant further investigations. This review presents an overview of recently published papers highlighting the risk factors, mechanisms, and treatment of AR. Additionally, recent studies discussing the role of single nucleotide polymorphism, DNA methylation, regulatory B cells, group 2 innate lymphoid cells, immunotherapy, and biologics in AR are also covered.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2018]版：

大类 | 1 区

医学

小类 | 1 区过敏 2 区免疫学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区免疫学 2 区过敏

JCR分区：

出版当年[2017]版：

Q1 IMMUNOLOGY Q1 ALLERGY

最新[2023]版：

Q1 IMMUNOLOGY Q1 ALLERGY

影响因子： 12.6 最新[2023版] 11.8 最新五年平均 6.048 出版当年[2017版] 6.549 出版当年五年平均 7.361 出版前一年[2016版] 6.771 出版后一年[2018版]

第一作者：

第一作者机构： [1]Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China

通讯作者：

通讯机构： [1]Capital Med Univ, Beijing TongRen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing 100730, Peoples R China [2]Beijing Inst Otolaryngol, Beijing Key Lab Nasal Dis, Beijing, Peoples R China [3]Capital Med Univ, Beijing TongRen Hosp, Dept Allergy, Beijing, Peoples R China [*1]Beijing Institute of Otolaryngology, No. 17, HouGouHuTong, DongCheng District, Beijing 100005, China. [*2]Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing 100730, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Advances and novel developments in allergic rhinitis [2]Current challenges with adherence to pharmacotherapy in allergic rhinitis [3]Risk and protective factors for coronavirus disease 2019 (COVID-19) in allergic rhinitis patients: a national survey in China [4]Association Between Immune-Related Disease and Allergic Rhinitis: A Two-Sample Mendelian Randomization Study [5]Prevalence and risk factors for allergic rhinitis in adults and children living in different grassland regions of Inner Mongolia [6]Prevalence and risk factors of allergic rhinitis and asthma in the southern edge of the plateau grassland region of northern China: A cross-sectional study [7]Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis [8]Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study [9]The Clinical Use of Cetirizine in the Treatment of Allergic Rhinitis [10]Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis